Kevin Sack - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Kevin Sack's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Kevin Sack

Kevin Sack

Verified

Investigative and Narrative Projects Reporter, The New York Times

Charleston

Doesn’t Cover

Finance, crime

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

Content

Total articles 243

  • Patient-specific in silico prediction of outcomes of partial continuous-flow LVAD treatment in peripartum cardiomyopathy

    By Kevin Sack Verified, Juliet Nagawa, Ngaka John Nchejane, Yawovi Dodzi Motchon| medRxiv@ The authors have declared no competing interest. This work was financially supported by DAAD-AIMS In-Region PhD scholarship South Africa, the National Research Foundation of South Africa (IFR14011761118 to TF), the CSIR Centre for High Performance Computing (CHPC Flagship Project Grant IRMA9543 to TF), and the Dr. Leopold und Carmen Ellinger Stiftung (UCT Three-Way PhD Global Partnership Programme Grant DAD937134 to TF).

    By Kevin Sack Verified, Juliet Nagawa, Ngaka John Nchejane, Yawovi Dodzi Motchon · medRxiv

    Sep. 19, 2024

  • In silico mechanics of stem cells intramyocardially transplanted with a biomaterial injectate for treatment of myocardial infarction

    By Y Dodzi Motchon, Kevin Sack Verified, Mazin S Sirry, N John Nchejane| bioRxiv@ AbstractPurpose: Biomaterial and stem cell delivery are promising approaches to treating myocardial infarction. However, the mechanical and biochemical mechanisms underlying the observed therapeutic benefits require further clarification. This study aimed to assess the deformation of stem cells injected with the biomaterial into the infarcted heart.

    By Y Dodzi Motchon, Kevin Sack Verified, Mazin S Sirry, N John Nchejane · bioRxiv

    Mar. 27, 2024

  • Patient-specific in silico prediction of outcomes of partial continuous-flow LVAD treatment in peripartum cardiomyopathy

    By Kevin Sack Verified, Juliet Nagawa, Ngaka John Nchejane, Yawovi Dodzi Motchon| medRxiv@ The authors have declared no competing interest. This work was financially supported by DAAD-AIMS In-Region PhD scholarship South Africa, the National Research Foundation of South Africa (IFR14011761118 to TF), the CSIR Centre for High Performance Computing (CHPC Flagship Project Grant IRMA9543 to TF), and the Dr. Leopold und Carmen Ellinger Stiftung (UCT Three-Way PhD Global Partnership Programme Grant DAD937134 to TF).

    By Kevin Sack Verified, Juliet Nagawa, Ngaka John Nchejane, Yawovi Dodzi Motchon · medRxiv

    Sep. 19, 2024

As seen in

Company Info

The New York Times

New York, New York, United States

+1 800-698-4637